The Glycogen Storage Disorder (GSD) Gene Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect genetic mutations associated with various types of Glycogen Storage Disorders. GSDs are a group of inherited metabolic conditions that affect the body's ability to store and release glucose from glycogen, leading to a range of symptoms from mild to severe, including muscle weakness, liver dysfunction, and in some cases, life-threatening complications.
This gene panel test specifically targets the genes known to be associated with the different forms of GSD, making it an essential step in confirming a diagnosis, understanding the specific type of GSD, and guiding treatment strategies. The test involves analyzing the patient's DNA to identify mutations in the genes related to glycogen storage and metabolism.
At DNA Labs UAE, the Glycogen Storage Disorder Gene Panel Test is priced at 7200 AED. The test process is streamlined and conducted by experienced professionals, ensuring accuracy and reliability in the results. Once the test is completed, genetic counselors at DNA Labs UAE can provide valuable insights into the implications of the test results, potential treatments, and management strategies for individuals diagnosed with a Glycogen Storage Disorder.
The Haemophilia A and B Gene Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the genes responsible for haemophilia A and B. Haemophilia A, also known as classic haemophilia, is primarily caused by mutations in the F8 gene, leading to a deficiency in clotting factor VIII. Haemophilia B, on the other hand, results from mutations in the F9 gene, which causes a deficiency in clotting factor IX. Both conditions are inherited in an X-linked recessive pattern, predominantly affecting males.
This gene panel test is a crucial step in diagnosing these bleeding disorders, enabling healthcare providers to make informed decisions regarding treatment plans and management strategies. It involves analyzing the patient's DNA to identify any genetic mutations associated with haemophilia A and B, offering a high degree of accuracy and specificity.
Priced at 7200 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring quality and reliability. The cost reflects the comprehensive nature of the test, covering a detailed analysis that can guide patient care and inform family planning decisions for those affected by or carriers of haemophilia. By opting for this test, patients and their families gain valuable insights into their genetic makeup, empowering them with information crucial for managing the condition effectively.
The HBOC Extended Panel Hereditary Breast and Ovarian Cancer 32 Genes Test is a comprehensive genetic screening designed to identify mutations across 32 genes associated with an increased risk of developing hereditary breast and ovarian cancer. This advanced test, available at DNA Labs UAE, serves as a crucial tool for individuals with a family history of these cancers, enabling them to take proactive steps in managing their health. The test is meticulously designed to provide a thorough genetic risk assessment, offering insights that can guide personalized prevention and surveillance strategies. By analyzing a wide array of genes beyond the well-known BRCA1 and BRCA2, the test ensures a more comprehensive understanding of an individual's genetic predisposition to breast and ovarian cancers. At a cost of 7200 AED, the test represents a significant investment in personal health, empowering patients with critical information to make informed decisions about their cancer risk management.
The Hemochromatosis HFE Full Gene Sequence Analysis Test is a comprehensive genetic screening designed to detect mutations in the HFE gene, which are commonly associated with hereditary hemochromatosis. Hereditary hemochromatosis is a genetic disorder that causes the body to absorb an excessive amount of iron from the diet, leading to iron overload in various organs and tissues. If left untreated, this condition can result in significant health issues, including liver disease, heart problems, diabetes, and arthritis.
The test involves analyzing the entire gene sequence of HFE to identify mutations that may predispose an individual to developing hemochromatosis. This level of analysis can provide valuable information for individuals with a family history of the condition or those exhibiting symptoms related to iron overload.
Performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the Hemochromatosis HFE Full Gene Sequence Analysis Test is priced at 7200 AED. The cost reflects the comprehensive nature of the test, employing cutting-edge technology to ensure accurate and reliable results. By opting for this test, individuals can gain insights into their genetic risk for hemochromatosis, enabling them to take proactive steps in managing their health in consultation with healthcare professionals.
The Hereditary Spastic Paraplegia (HSP) Gene Panel Test is a comprehensive diagnostic tool available at DNA Labs UAE, designed to identify genetic mutations associated with Hereditary Spastic Paraplegia. HSP is a group of inherited disorders that cause progressive stiffness and weakness in the leg muscles due to the degeneration of the upper motor neurons. Given the complexity of HSP, which can be linked to mutations in various genes, this panel test screens multiple genes simultaneously to pinpoint the specific genetic alterations responsible for the condition in an individual.
Priced at 7200 AED, the test aims to offer a targeted approach in diagnosing HSP, facilitating personalized treatment plans and management strategies for affected individuals. It is particularly valuable for patients exhibiting symptoms of HSP or those with a family history of the disorder, providing crucial insights into the genetic underpinnings of their condition. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the HSP Gene Panel Test stands as a critical resource for patients and healthcare providers in the quest for accurate diagnosis and effective management of Hereditary Spastic Paraplegia.
Leigh Syndrome, also known as Mitochondrial Encephalopathy, is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities, which can lead to severe neurological and physical impairment. Leigh Syndrome is caused by genetic mutations affecting the mitochondria, the energy-producing structures within cells, leading to energy production failure and, subsequently, cell death, particularly in the brain, muscles, and heart.
To diagnose this complex condition, a Mitochondrial Encephalopathy Gene Panel Test is utilized. This comprehensive genetic test screens for mutations in multiple genes known to be associated with Leigh Syndrome and other mitochondrial disorders. By examining a broad panel of genes, this test provides a more accurate diagnosis, guiding treatment options and management strategies for affected individuals.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the Mitochondrial Encephalopathy Gene Panel Test is 7200 AED. Conducting the test in a specialized and reputable laboratory like DNA Labs UAE ensures high accuracy and reliability of the results, which is crucial for the effective management of Leigh Syndrome and related mitochondrial disorders. This test is a critical step in the journey towards understanding and managing these complex conditions, offering hope for affected families through precise diagnosis and the potential for targeted therapies.
The Lung Cancer Panel 5 EGFRKRASBRAFALK1ROS1 Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations in lung cancer patients. This panel tests for alterations in five critical genes: EGFR, KRAS, BRAF, ALK1, and ROS1, which are known to play significant roles in the development and progression of lung cancer. By detecting mutations in these genes, the test can help guide personalized treatment plans, including targeted therapies that may improve patient outcomes. The cost of the test is 7200 AED, making it a valuable investment for those seeking advanced, personalized cancer care. Through its precise identification of genetic mutations, the Lung Cancer Panel 5 provides crucial insights that can lead to more effective and tailored treatment strategies for individuals battling lung cancer.
The "Lung Cancer Panel 7 EGFRBRAFALK1ROS1 MET Test" is a comprehensive genomic test offered by DNA Labs UAE, designed to identify genetic mutations in lung cancer patients. This panel specifically targets mutations in seven critical genes: EGFR, BRAF, ALK, ROS1, and MET, which are known to influence the growth and spread of lung cancer cells. By detecting these mutations, the test provides essential information that can guide personalized treatment plans, including targeted therapies that may offer better outcomes for patients.
The cost of the test is 7200 AED. Conducted in the advanced facilities of DNA Labs UAE, this test represents a significant step forward in the precision medicine approach to treating lung cancer, allowing for more tailored and effective treatment strategies based on the genetic profile of an individual's cancer.
The Lysosomal Storage Disorder (LSD) Gene Panel Test is a comprehensive genetic screening designed to identify mutations in genes associated with lysosomal storage disorders, a group of rare inherited metabolic conditions. This panel test is crucial for the early diagnosis and management of these disorders, enabling healthcare providers to tailor treatment plans effectively. By analyzing a wide range of genes linked to various forms of LSDs, the test offers a detailed insight into the genetic underpinnings of these conditions, which can include Gaucher disease, Fabry disease, Pompe disease, and many others.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability in results, thanks to their state-of-the-art technology and expert team. The cost of the Lysosomal Storage Disorder Gene Panel Test is set at 7200 AED, reflecting the comprehensive nature of the analysis and the significant value it provides in guiding patient care and genetic counseling. This test is a vital tool for individuals with a family history of lysosomal storage disorders or presenting symptoms suggestive of these conditions, offering a path towards a clearer understanding of their health and proactive management options.
The Metabolic Disorder Gene Panel Test, available at DNA Labs UAE, is a comprehensive diagnostic tool designed to identify genetic mutations associated with a wide range of metabolic disorders. Priced at 7200 AED, this advanced genetic test offers a deep insight into the genetic factors that may contribute to metabolic issues, allowing for precise diagnosis, informed treatment decisions, and personalized management plans. By examining specific genes known to affect metabolism, the test can uncover genetic predispositions to conditions such as lipid metabolism disorders, mitochondrial disorders, and various inborn errors of metabolism. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is a crucial step towards proactive health management and tailored healthcare, providing individuals and families with critical information to address metabolic disorders effectively.
